Table 3.
Treatment-associated AEs | HA filling plus mesotherapy combined treatment group, n (%) | BTX-A treatment group, n (%) | P value |
---|---|---|---|
Lumps | 2 (8) | — | — |
Erythema | 25 (100) | 22 (95.7) | 0.479 |
Topical edema and swelling | 25 (100) | 2 (8.7) | 0.000 |
Ecchymosis | 14 (56) | 7 (30.4) | 0.074 |
Tyndall effect | 2 (8) | — | — |
Trachyphonia | — | 1 (4.3) | — |
Rashes and itchiness | 3 (12) | — | — |
AE, adverse event; BTX-A, botulinum toxin A; HA, hyaluronic acid.